IL155668A0 - Novel farnesyl protein transferase inhibitors - Google Patents

Novel farnesyl protein transferase inhibitors

Info

Publication number
IL155668A0
IL155668A0 IL15566801A IL15566801A IL155668A0 IL 155668 A0 IL155668 A0 IL 155668A0 IL 15566801 A IL15566801 A IL 15566801A IL 15566801 A IL15566801 A IL 15566801A IL 155668 A0 IL155668 A0 IL 155668A0
Authority
IL
Israel
Prior art keywords
protein transferase
transferase inhibitors
farnesyl protein
novel farnesyl
novel
Prior art date
Application number
IL15566801A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL155668A0 publication Critical patent/IL155668A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15566801A 2000-11-29 2001-11-27 Novel farnesyl protein transferase inhibitors IL155668A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25397100P 2000-11-29 2000-11-29
PCT/US2001/044333 WO2002044164A1 (en) 2000-11-29 2001-11-27 0ovel farnesyl protein transferase inhibitors

Publications (1)

Publication Number Publication Date
IL155668A0 true IL155668A0 (en) 2003-11-23

Family

ID=22962414

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15566801A IL155668A0 (en) 2000-11-29 2001-11-27 Novel farnesyl protein transferase inhibitors

Country Status (20)

Country Link
US (1) US6528523B2 (de)
EP (1) EP1337522B1 (de)
JP (1) JP2004514717A (de)
KR (1) KR20030060939A (de)
CN (1) CN1198816C (de)
AR (1) AR035660A1 (de)
AT (1) ATE371655T1 (de)
AU (2) AU3514302A (de)
CA (1) CA2429720C (de)
DE (1) DE60130239T2 (de)
ES (1) ES2291368T3 (de)
HK (1) HK1054226A1 (de)
HU (1) HUP0302104A2 (de)
IL (1) IL155668A0 (de)
MX (1) MXPA03004878A (de)
NZ (1) NZ525572A (de)
PE (1) PE20020635A1 (de)
TW (1) TWI225058B (de)
WO (1) WO2002044164A1 (de)
ZA (1) ZA200303635B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4691041B2 (ja) 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
US7826982B2 (en) 2005-07-29 2010-11-02 Children's Hospital Medical Center Method of identifying inhibitors using a 3-D structure of RAC-1 GTPASE
US9980942B2 (en) 2012-05-02 2018-05-29 Children's Hospital Medical Center Rejuvenation of precursor cells
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same
CN114450027A (zh) 2019-08-16 2022-05-06 儿童医院医疗中心 用cdc42特异性抑制剂治疗受试者的方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL111257A0 (en) * 1993-10-15 1994-12-29 Schering Corp Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5719148A (en) 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5700806A (en) 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5684013A (en) 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5801175A (en) 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL125062A (en) * 1995-12-22 2003-11-23 Schering Corp Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases
US5874442A (en) 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US5784442A (en) 1996-02-02 1998-07-21 Telefonaktiebologet Lm Ericsson (Publ) System and method for real-time billing in a radio telecommunications network
US5925757A (en) * 1996-07-26 1999-07-20 Schering Corporation Method for preparing carboxamides
US6040305A (en) 1996-09-13 2000-03-21 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6030982A (en) 1996-09-13 2000-02-29 Schering Corporationm Compounds useful for inhibition of farnesyl protein transferase
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
US5945429A (en) 1996-09-13 1999-08-31 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6071907A (en) 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5985879A (en) 1996-09-13 1999-11-16 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6358968B1 (en) 1997-06-17 2002-03-19 Schering Corporation N-substituted urea inhibitors of farnesyl-protein transferase
US6239140B1 (en) 1997-06-17 2001-05-29 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5925639A (en) 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
US6159984A (en) 1997-06-17 2000-12-12 Schering Corporation Farnesyl protein transferase inhibitors
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5939416A (en) 1997-06-17 1999-08-17 Schering Corporation Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
IL133449A0 (en) * 1997-06-17 2001-04-30 Schering Corp Benzo (5, 6) cyclohepta (1, 2-b) pyridine derivatives as farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
AU8253698A (en) * 1997-06-17 1999-01-04 Schering Corporation Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
US5852034A (en) 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6051582A (en) 1997-06-17 2000-04-18 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6221322B1 (en) 1997-11-27 2001-04-24 Dowa Mining Co., Ltd Strontium nitrate and method for manufacturing same
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
US6432959B1 (en) 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US6410451B2 (en) 1999-09-27 2002-06-25 Lam Research Corporation Techniques for improving etching in a plasma processing chamber

Also Published As

Publication number Publication date
DE60130239T2 (de) 2008-05-21
HK1054226A1 (zh) 2003-11-21
CN1198816C (zh) 2005-04-27
DE60130239D1 (en) 2007-10-11
CA2429720C (en) 2009-12-29
US20020115679A1 (en) 2002-08-22
PE20020635A1 (es) 2002-07-11
HUP0302104A2 (hu) 2003-09-29
ZA200303635B (en) 2004-08-12
AR035660A1 (es) 2004-06-23
NZ525572A (en) 2004-11-26
AU3514302A (en) 2002-06-11
EP1337522B1 (de) 2007-08-29
US6528523B2 (en) 2003-03-04
WO2002044164A1 (en) 2002-06-06
KR20030060939A (ko) 2003-07-16
ATE371655T1 (de) 2007-09-15
JP2004514717A (ja) 2004-05-20
ES2291368T3 (es) 2008-03-01
CN1476444A (zh) 2004-02-18
EP1337522A1 (de) 2003-08-27
MXPA03004878A (es) 2003-08-19
AU2002235143B2 (en) 2006-03-02
TWI225058B (en) 2004-12-11
CA2429720A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001246477A1 (en) Farnesyl protein transferase inhibitor combinations with platinum compounds
IL143409A0 (en) Farnesyl protein transferase inhibitors
ZA985778B (en) Inhibitors of farnesyl protein transferase.
AU2001240658A1 (en) Farnesyl protein transferase inhibitor combinations with camptothecin compounds
EP1324985A4 (de) Hemmstoffe der prenyl-protein transferase
EP1165082A4 (de) Inhibitoren der prenyl-protein-transferase
AU2001235496A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
AU2001252147A1 (en) Farnesyl protein transferase inhibitor combinations
AU2001247882A1 (en) Tricyclic protein kinase inhibitors
AU2001244166A1 (en) Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
AU2001246478A1 (en) Farnesyl protein transferase inhibitor combinations with taxane compounds
AU2001253197A1 (en) Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
IL154528A0 (en) Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
IL163673A0 (en) Farnesyl protein transferase inhibitors as antitumor agents
EP1158982A4 (de) Inhibitoren der Prenyl-Protein Transferase
DK1339695T3 (da) Farnesyltransferase-inhibitorer
HUP0202152A2 (en) Tricyclyc farnesyl protein transferase inhibitors
PL355887A1 (en) Farnesyl transferase inhibitors
AU2435199A (en) Farnesyl transferase inhibitors
IL155668A0 (en) Novel farnesyl protein transferase inhibitors
GB0012216D0 (en) Glycosyltransferase protein
IL149870A0 (en) Inhibitors of farnesyl protein transferase
HK1047742A (en) Farnesyl transferase inhibitors
HK1036975A (en) Tricyclic farnesyl protein transferase inhibitors
IL141626A0 (en) Farnesyl transferase inhibitors